Your essential source for the latest news on the intersection of Wall Street and Washington.
Tracking the Debate Over Health Care Reform
Politics, politicians, big business and the economy
Something is awry in the RSS feed. We're working on it.
December 17, 2009; 2:42 PM ET
Save & Share:
Next: Five cost controls in the Senate health-care bill
Is this true? There are several sets of fingerprints in the Senate chamber where (drug importation) legislation died, including some from the White House, says Sen. Byron Dorgan (D-ND). "They did not support this," and worked with Democratic Senate leaders to kill it in order to move the larger bill forward, he said in an interview. The amendment failed in the Senate Tuesday evening...
Dorgan said he can't get answers from the administration about what's going on, though he called the White House and FDA prior to the vote.
Last week, he said he heard rumors that the FDA was going to send a letter objecting to drug importation on safety grounds, which he has said is a bogus reason. He said he called FDA Commissioner Margaret Hamburg, who said she knew nothing about such a letter.
He said his timeline shows that a letter, signed by Hamburg questioning the safety of drug imports, was sent 24 hours later to a few senators who opposed importation. That piece of paper became a rallying cry for other senators who voted down Dorgan's amendment.
"I think the letter was prompted, probably drafted somewhere else," like "the White House" Dorgan said.
The White House has not responded to repeated calls and emails. The FDA did not immediately comment.
Posted by: obrier2 | December 17, 2009 3:58 PM
| Report abuse
The comments to this entry are closed.